Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Mafalda Calheiros-LoboUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.ORCID 0000-0002-9578-3372
João P N SilvaUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.ORCID 0000-0003-4455-4286
Leonor DelgadoUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
Bárbara PintoUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
Luís MonteiroUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.ORCID 0000-0002-8938-1297
Carlos LopesUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
Patrícia M A SilvaUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.ORCID 0000-0002-0694-7321
Hassan BousbaaUNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.ORCID 0000-0002-4006-5779
Funding
CESPU-Cooperativa de Ensino Superior Politécnico e Univer-sitário Crl AntiMitoSphere_APSFCT_IINFACTS_2021CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl BD/CBAS/CESPU/01/2020CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl BD/CBAS/CESPU/01/2021CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl BeatCancer-GI2-CESPU-2023CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl Flav4Tumor-GI2-CESPU- 2022CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl SGA4Cancer-GI2-CESPU-2022CESPU-Cooperativa de Ensino Superior Politécnico e Universitário Crl upPTXovcar-GI2-CESPU-2022Fundação para a Ciência e Tecnologia 2022.09451.BD
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
antimitoticsantitumor activityaurora-B inhibitorcetuximabcombination treatmentKSP inhibitorMPS-1 inhibitororal cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer: A Plausible Alliance to Enhance Cell Death. · full record | OpenQuestion